Clinical Study
Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain
Table 1
Clinical and demographic characteristics of patients at baseline.
| ||||||||||||||||||||||||||||||||
Main clinical and demographic characteristics of patients affected by diabetic neuropathy and traumatic neuropathy at baseline. VAS: Visual Analogue Scale; NPSI: Neuropathic Pain Symptom Inventory; EQ-5D: health questionnaire five dimensions. |